Power of Attorney Appointment

This filing indicates that Christopher M. Murphy, Chief Financial Officer of AnaptysBio, Inc., has appointed Daniel Faga and Dave McKeon as his attorneys-in-fact. This appointment authorizes them to execute and file all necessary Form 3, 4, or 5 reports with the SEC and any stock exchanges on Mr. Murphy's behalf, in accordance with Section 16(a) of the Securities Exchange Act of 1934. The attorneys-in-fact are empowered to take any action deemed necessary or beneficial for these filings. This Power of Attorney remains effective until Mr. Murphy is no longer required to file such reports or until it is revoked in writing. The appointment was effective as of May 8, 2026, with the filing dated May 13, 2026.